Stroke/Vascular Neurology News

The FDA approved an expanded indication for a transcarotid stent system to include patients at standard risk for adverse events from carotid endarterectomy, according to a press release from Silk Road Medical.

The benefits of ticagrelor and aspirin outweighed the risk for major hemorrhage in patients with mild to moderate ischemic stroke or at high risk for transient ischemic attack during 30 days of treatment, according to a Neurology study.

Women were less likely to return to work after large vessel occlusion stroke compared with men, despite similar 90-day functional outcomes, according to study findings published in Stroke.

Bendit Technologies announced it received FDA 510(k) clearance for its steerable microcatheter platform for treatment in the neurologic, peripheral and coronary vasculature.

SEATTLE — Patients with acute ischemic stroke need access to lifesaving thrombectomy in all areas of the world, a speaker said at the 2022 American Academy of Neurology annual meeting.

In this week's edition, the FDA approval of a transdermal patch to treat Alzheimer’s-related dementia; the link between daily napping and an increased risk for Alzheimer’s disease; an oral treatment for Parkinson’s; and more.

SEATTLE — Mobile stroke units were linked with improved outcomes compared with conventional emergency medical services for people with acute ischemic stroke, a presenter said at the 2022 American Academy of Neurology annual meeting.

WASHINGTON — Among patients with MI, those diagnosed with depression after the event had greater risk for stroke than those without depression, according to findings presented at the American College of Cardiology Scientific Session.

New-onset CV complications after ischemic stroke predicts worse 5-year prognosis for major adverse CV events, including death, according to new research published in Stroke.

Natalia S. Rost, MD, MPH, chair of the AAN science committee, led a discussion to highlight select studies being presented at the AAN’s annual meeting April 2-7 in Seattle.